nach oben

European Journal of Nuclear Medicine and Molecular Imaging

Erschienen in:

11.01.2020 | Editorial

Ethical principles for the application of artificial intelligence (AI) in nuclear medicine

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 4/2020

Einloggen, um Zugang zu erhalten

Excerpt

The emergence of artificial intelligence (AI) in Nuclear Medicine, and the promise of synthetic intelligence, heralds an era of disruptive technology with the potential to re-invigorate the ecosystem of Nuclear Medicine and reengineer the landscape in which Nuclear Medicine is practiced. While AI is not new in Nuclear Medicine, more recent developments and applications of machine learning and deep learning create refreshed interest in the ethical issues associated with AI implementation in Nuclear Medicine. Insight into the architecture, operation and implementation of AI in Nuclear Medicine is beyond the scope of this discussion and has been reported elsewhere (1‐3). Nonetheless, it is important to provide key definitions. …

Currie G. Intelligent imaging: artificial intelligence augmented nuclear medicine. Journal of Nuclear Medicine Technology. 2019;47:217–22.CrossRef

Currie G. Intelligent Imaging: anatomy of machine learning and deep learning. Journal of Nuclear Medicine Technology. 2019;47(4):273–81.CrossRef

Currie G, Hawk KE, Rohren E, Vial A, Klein R. Machine learning and deep learning in medical imaging: intelligent imaging. Journal of Medical Imaging and Radiation Sciences. 2019;50(4):477–87.CrossRef

Hamlet P, Tremblay J. Artificial intelligence in medicine. Metabolism clinical and experimental. 2017;69:S36–40.CrossRef

SFR-IA Group, CERF. Artificial intelligence and medical imaging 2018: French radiology community white paper. Diagn Interv Radiol. 2018;99:727–42.

Geis JR, Brady A, Wu C, et al. Ethics of artificial intelligence in radiology: summary of the joint European and north American multisociety statement. Insights into Imaging. 2019. https://doi.org/10.1186/s13244-019-0785-8.

Jalal S, Nicolaou S, Parker W. Artificial intelligence, radiology, and the way forward. Can Assoc Radiol J. 2019;70:10–2.CrossRef

Balthazar P, Harri P, Prater A, Safdar NM. Protecting your patients' interests in the era of big data, artificial intelligence, and predictive analytics. J Am Coll Radiol. 2018;153:580–6.CrossRef

Jaremko JL, Azar M, Bromwich R, et al. Canadian Association of Radiologists white paper on ethical and legal issues related to artificial intelligence in radiology. Can Assoc Radiol J. 2019;70:107–18.CrossRef

10.

Kohli M, Geis R. Ethics, artificial intelligence, and radiology. J Am Coll Radiol. 2018;15:1317–9.CrossRef

11.

Ploug T, Holm S. The right to refuse diagnostics and treatment planning by artificial intelligence. Health Care and Philosophy: Medicine; 2019. https://doi.org/10.1007/s11019-019-09912-8.CrossRef

12.

Floridi L, Cowls J, Beltrametti M, et al. AI4People – an ethical framework for a good AI society: opportunities, risks, principles, and recommendations. Mind Mach. 2018;28:689–707.CrossRef

13.

Future of life institute. Asilomar AI principles, Asilomar Conference on Beneficial AI. 2017. https://futureoflife.org/ai-principles/.

14.

Reddy S, Allan S, Coghlan S, Cooper P. A governance model for the application of AI in health care. J Amercian Medical Informatics Association. 2019. https://doi.org/10.1093/jamia/ocz192.CrossRef

Titel: Ethical principles for the application of artificial intelligence (AI) in nuclear medicine
Publikationsdatum: 11.01.2020
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 4/2020
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-020-04678-1

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2020

Quantifying the effects of absorbed dose from radioembolisation on healthy liver function with [99mTc]TcMebrofenin

Comparative dosimetry between 99mTc-MAA SPECT/CT and 90Y PET/CT in primary and metastatic liver tumors

[89Zr]Zr-cetuximab PET/CT as biomarker for cetuximab monotherapy in patients with RAS wild-type advanced colorectal cancer

Correction to: A multiparametric analysis based on DCE-MRI to improve the accuracy of parotid tumor discrimination

The superior predictive value of 166Ho-scout compared with 99mTc-macroaggregated albumin prior to 166Ho-microspheres radioembolization in patients with liver metastases

Hypoxia-induced modulation of glucose transporter expression impacts 18F-fluorodeoxyglucose PET-CT imaging in hepatocellular carcinoma